Genotype-Tailored ERK/MAPK Pathway and HDAC Inhibition Rewires the Apoptotic Rheostat to Trigger Colorectal Cancer Cell Death

The EGFR/RAS/MEK/ERK signaling pathway (ERK/MAPK) is hyperactivated in most colorectal cancers. A current limitation of inhibitors of this pathway is that they primarily induce cytostatic effects in colorectal cancer cells. Nevertheless, these drugs do induce expression of proapoptotic factors, sugg...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenkins, Laura J., Luk, Ian Y., Fairlie, W. Douglas, Lee, Erinna F., Palmieri, Michelle, Schoffer, Kael L., Tan, Tao, Ng, Irvin, Vukelic, Natalia, Tran, Sharon, Tse, Janson W.T., Nightingale, Rebecca, Alam, Zakia, Chionh, Fiona, Iatropoulos, George, Ernst, Matthias, Afshar-Sterle, Shoukat, Desai, Jayesh, Gibbs, Peter, Sieber, Oliver M., Dhillon, Amardeep S., Tebbutt, Niall C., Mariadason, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Small Molecule Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808369/
https://www.ncbi.nlm.nih.gov/pubmed/36343387
http://dx.doi.org/10.1158/1535-7163.MCT-22-0101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808369/
https://www.ncbi.nlm.nih.gov/pubmed/36343387
http://dx.doi.org/10.1158/1535-7163.MCT-22-0101

Ejemplares similares